Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Lewis, Caroline
Carberry, Steven
and
Ohlendieck, Kay
2009.
Proteomic profiling of x-linked muscular dystrophy.
Journal of Muscle Research and Cell Motility,
Vol. 30,
Issue. 7-8,
p.
267.
Bushby, Kate
Lochmüller, Hanns
Lynn, Stephen
and
Straub, Volker
2009.
Interventions for muscular dystrophy: molecular medicines entering the clinic.
The Lancet,
Vol. 374,
Issue. 9704,
p.
1849.
Sandonà, Dorianna
and
Betto, Romeo
2009.
Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects.
Expert Reviews in Molecular Medicine,
Vol. 11,
Issue. ,
Chamberlain, Jeffrey S.
2010.
Duchenne Muscular Dystrophy Models Show Their Age.
Cell,
Vol. 143,
Issue. 7,
p.
1040.
Spitali, Pietro
Heemskerk, Hans
Vossen, Rolf HAM
Ferlini, Alessandra
den Dunnen, Johan T
't Hoen, Peter AC
and
Aartsma-Rus, Annemieke
2010.
Accurate quantification of dystrophin mRNA and exon skipping levels in Duchenne Muscular Dystrophy.
Laboratory Investigation,
Haurigot, Virginia
Mingozzi, Federico
Buchlis, George
Hui, Daniel J
Chen, Yifeng
Basner-Tschakarjan, Etiena
Arruda, Valder R
Radu, Antoneta
Franck, Helen G
Wright, J Fraser
Zhou, Shangzhen
Stedman, Hansell H
Bellinger, Dwight A
Nichols, Timothy C
and
High, Katherine A
2010.
Safety of AAV Factor IX Peripheral Transvenular Gene Delivery to Muscle in Hemophilia B Dogs.
Molecular Therapy,
Vol. 18,
Issue. 7,
p.
1318.
Ten Broek, Roel W.
Grefte, Sander
and
Von den Hoff, Johannes W.
2010.
Regulatory factors and cell populations involved in skeletal muscle regeneration.
Journal of Cellular Physiology,
Vol. 224,
Issue. 1,
p.
7.
Bidou, Laure
and
Allamand, Valérie
2010.
Encyclopedia of Life Sciences.
Carter, Gregory T.
Han, Jay J.
Chamberlain, Joel R.
and
Chamberlain, Jeffrey S.
2010.
On fixing broken muscle…fall seven times, stand up eight—Japanese proverb.
Muscle & Nerve,
Vol. 41,
Issue. 6,
p.
737.
Spitali, Pietro
Heemskerk, Hans
Vossen, Rolf HAM
Ferlini, Alessandra
den Dunnen, Johan T
't Hoen, Peter AC
and
Aartsma-Rus, Annemieke
2010.
Accurate quantification of dystrophin mRNA and exon skipping levels in Duchenne Muscular Dystrophy.
Laboratory Investigation,
Vol. 90,
Issue. 9,
p.
1396.
Incitti, Tania
De Angelis, Fernanda G
Cazzella, Valentina
Sthandier, Olga
Pinnarò, Chiara
Legnini, Ivano
and
Bozzoni, Irene
2010.
Exon Skipping and Duchenne Muscular Dystrophy Therapy: Selection of the Most Active U1 snRNA Antisense Able to Induce Dystrophin Exon 51 Skipping.
Molecular Therapy,
Vol. 18,
Issue. 9,
p.
1675.
Odom, Guy L.
Banks, Glen B.
Schultz, Brian R.
Gregorevic, Paul
and
Chamberlain, Jeffrey S.
2010.
Preclinical Studies for Gene Therapy of Duchenne Muscular Dystrophy.
Journal of Child Neurology,
Vol. 25,
Issue. 9,
p.
1149.
Yablonka-Reuveni, Zipora
2011.
The Skeletal Muscle Satellite Cell.
Journal of Histochemistry & Cytochemistry,
Vol. 59,
Issue. 12,
p.
1041.
Henderson, Davin M.
Belanto, Joseph J.
Li, Bin
Heun-Johnson, Hanke
and
Ervasti, James M.
2011.
Internal deletion compromises the stability of dystrophin.
Human Molecular Genetics,
Vol. 20,
Issue. 15,
p.
2955.
Henningsen, Jeanette
Pedersen, Bente Klarlund
and
Kratchmarova, Irina
2011.
Quantitative analysis of the secretion of the MCP family of chemokines by muscle cells.
Mol. BioSyst.,
Vol. 7,
Issue. 2,
p.
311.
Mann, Christopher J
Perdiguero, Eusebio
Kharraz, Yacine
Aguilar, Susana
Pessina, Patrizia
Serrano, Antonio L
and
Muñoz-Cánoves, Pura
2011.
Aberrant repair and fibrosis development in skeletal muscle.
Skeletal Muscle,
Vol. 1,
Issue. 1,
Wu, Melissa P.
and
Gussoni, Emanuela
2011.
Carbamylated erythropoietin does not alleviate signs of dystrophy in mdx mice.
Muscle & Nerve,
Vol. 43,
Issue. 1,
p.
88.
Partridge, Terence A.
2011.
Impending therapies for Duchenne muscular dystrophy.
Current Opinion in Neurology,
Vol. 24,
Issue. 5,
p.
415.
Cozzoli, A.
Rolland, J.-F.
Capogrosso, R. F.
Sblendorio, V. T.
Longo, V.
Simonetti, S.
Nico, B.
and
De Luca, A.
2011.
Evaluation of potential synergistic action of a combined treatment with alpha-methyl-prednisolone and taurine on the mdx mouse model of Duchenne muscular dystrophy.
Neuropathology and Applied Neurobiology,
Vol. 37,
Issue. 3,
p.
243.
Goonasekera, Sanjeewa A.
Lam, Chi K.
Millay, Douglas P.
Sargent, Michelle A.
Hajjar, Roger J.
Kranias, Evangelia G.
and
Molkentin, Jeffery D.
2011.
Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle.
Journal of Clinical Investigation,
Vol. 121,
Issue. 3,
p.
1044.